Selected Publications
Wasserman, R.L., Stein, M. R., Younger, M.E.M., Fatteh, S. & Haddad, E. (2016). 20% Subcutaneous immunoglobulin dosed biweekly for primary immunodeficiency. Annals of Allergy, Asthma and Immunology, 117(1), 93-94
Ballow, M., Sriaroon, P., Rachid, R., Seeborg, F., Duff, C., Bonilla, F., Younger, M. E. M., & Shapiro, R. (2017). Construction and Validation of a Disease-specific Quality of Life (HR-QOL) Instrument for Patients with Primary Antibody Deficiency Disease. Journal of Allergy and Clinical Immunology
Younger, M. E. M., Aro, L., Blouin, W., Duff, C., Epland. K. B., Murphy, E., & Sedlak, D. Nursing guidelines for administration of immunoglobulin replacement therapy. Journal of the Infusion Nurses Society 2013; 36(1), 58-68
Younger, M.E.M., Epland, K., Zampelli, A., & Hintermeyer, M.K. Identification, evaluation and management of primary immunodeficiency diseases: A review for primary care providers. The Nurse Practitioner 2015, 40(2):1-7
Younger, M. E. M., Blouin, W., Duff, C., Epland, K. B., Murphy, E., & Sedlak, D. Subcutaneous immunoglobulin replacement therapy: Ensuring success. Journal of Infusion Nursing 2015, 38(1), 70-79